Search Results

There are 14366 results for: content related to: Phase II trial of gemcitabine in advanced sarcomas

  1. Intravesical gemcitabine for non-muscle invasive bladder cancer

    Intervention Review

    The Cochrane Library

    Gabriel Jones, Anne Cleves, Timothy J Wilt, Malcolm Mason, Howard G Kynaston and Mike Shelley

    Published Online : 18 JAN 2012, DOI: 10.1002/14651858.CD009294.pub2

  2. You have free access to this content
    Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC): a systematic review

    BJU International

    Volume 109, Issue 4, February 2012, Pages: 496–505, Mike D. Shelley, Gabriel Jones, Anne Cleves, Timothy J. Wilt, Malcolm D. Mason and Howard G. Kynaston

    Version of Record online : 7 FEB 2012, DOI: 10.1111/j.1464-410X.2011.10880.x

  3. Gemcitabine for unresectable, locally advanced or metastatic bladder cancer

    Intervention Review

    The Cochrane Library

    Mike Shelley, Anne Cleves, Timothy J Wilt and Malcolm Mason

    Published Online : 13 APR 2011, DOI: 10.1002/14651858.CD008976.pub2

  4. You have free access to this content
    Gemcitabine chemotherapy for the treatment of metastatic bladder carcinoma

    BJU International

    Volume 108, Issue 2, July 2011, Pages: 168–179, Michael D. Shelley, Anne Cleves, Timothy J. Wilt and Malcolm D. Mason

    Version of Record online : 1 JUL 2011, DOI: 10.1111/j.1464-410X.2011.10341.x

  5. Validation of a hydrophilic interaction ultra-performance liquid chromatography–tandem mass spectrometry method for the determination of gemcitabine in human plasma with tetrahydrouridine

    Biomedical Chromatography

    Volume 29, Issue 9, September 2015, Pages: 1343–1349, Yuji Mano, Kenji Sakamaki, Takuya Ueno, Kenji Kita, Takuho Ishii, Koichiro Hotta and Kazutomi Kusano

    Version of Record online : 2 FEB 2015, DOI: 10.1002/bmc.3429

  6. You have free access to this content
    Identification of NME5 as a contributor to innate resistance to gemcitabine in pancreatic cancer cells

    The FEBS Journal

    Volume 279, Issue 7, April 2012, Pages: 1261–1273, Fu Li, Gang Hu, Zhenzhou Jiang, Jingjing Guo, Ke Wang, Kedong Ouyang, Danyi Wen, Minghua Zhu, Jiaxin Liang, Xiaoran Qin and Luyong Zhang

    Version of Record online : 12 MAR 2012, DOI: 10.1111/j.1742-4658.2012.08521.x

  7. You have free access to this content
    Synthesis and Biological Evaluation of Oral Prodrugs Based on the Structure of Gemcitabine

    Chemical Biology & Drug Design

    Volume 80, Issue 3, September 2012, Pages: 479–488, Cuirong Zhao, Xiaoxia Xue, Gang Li, Cuicui Sun, Changjun Sun, Xianjun Qu and Wenbao Li

    Version of Record online : 25 JUN 2012, DOI: 10.1111/j.1747-0285.2012.01422.x

  8. You have full text access to this Open Access content
    RNA interference-mediated silencing of the polo-like kinase 1 gene enhances chemosensitivity to gemcitabine in pancreatic adenocarcinoma cells

    Journal of Cellular and Molecular Medicine

    Volume 12, Issue 6a, December 2008, Pages: 2334–2349, C. Yu, X. Zhang, G. Sun, X. Guo, H. Li, Y. You, J. L. Jacobs, K. Gardner, D. Yuan, Z. Xu, Q. Du, C. Dai, Z. Qian, K. Jiang, Y. Zhu, Q. Q. Li and Y. Miao

    Version of Record online : 6 FEB 2008, DOI: 10.1111/j.1582-4934.2008.00257.x

  9. You have free access to this content
    Activation of c-Jun NH2-terminal kinase is required for gemcitabine's cytotoxic effect in human lung cancer H1299 cells

    FEBS Letters

    Volume 579, Issue 29, December 05, 2005, Pages: 6681–6687, Fuminori Teraishi, Lidong Zhang, Wei Guo, Fengqin Dong, John J. Davis, Anning Lin and Bingliang Fang

    Version of Record online : 14 NOV 2005, DOI: 10.1016/j.febslet.2005.10.064

  10. You have free access to this content
    Chemosensitization of gemcitabine-resistant human bladder cancer cell line both in vitro and in vivo using antisense oligonucleotide targeting the anti-apoptotic gene, clusterin

    BJU International

    Volume 103, Issue 3, February 2009, Pages: 384–390, Mototsugu Muramaki, Alan So, Norihiro Hayashi, Richard Sowery, Hideaki Miyake, Masato Fujisawa and Martin E. Gleave

    Version of Record online : 24 OCT 2008, DOI: 10.1111/j.1464-410X.2008.08098.x

  11. Synthesis and characterization of saccharide-functionalized polymer–gemcitabine conjugates based on chemoenzymatic selective strategy

    Journal of Applied Polymer Science

    Volume 124, Issue 3, 5 May 2012, Pages: 1840–1847, Guo-Jun Zhou, Xia Li, Ming-Xing Teng, Guo-Hai Chu and Xian-Fu Lin

    Version of Record online : 21 OCT 2011, DOI: 10.1002/app.35201

  12. Interstitial lung disease associated with gemcitabine: A Japanese retrospective cohort study

    Respirology

    Volume 21, Issue 2, February 2016, Pages: 338–343, Tsuyoshi Hamada, Hideo Yasunaga, Yousuke Nakai, Hiroyuki Isayama, Hiroki Matsui, Kiyohide Fushimi and Kazuhiko Koike

    Version of Record online : 2 NOV 2015, DOI: 10.1111/resp.12665

  13. Optimized sequence of drug administration and schedule leads to improved dose delivery for gemcitabine and paclitaxel in combination: a phase I trial in patients with recurrent ovarian cancer

    International Journal of Gynecological Cancer

    Volume 16, Issue 2, March/April 2006, Pages: 507–514, C.J. POOLE, T. PERREN, S. GAWANDE, M. RIDDERHEIM, J. COOK, A. JENKINS and D. ROYCHOWDHURY

    Version of Record online : 25 APR 2006, DOI: 10.1111/j.1525-1438.2006.00466.x

  14. Review of gemcitabine-based combinations for platinum-resistant ovarian cancer

    International Journal of Gynecological Cancer

    Volume 15, Issue s1, May 2005, Pages: 23–30, J. Sehouli

    Version of Record online : 11 APR 2005, DOI: 10.1111/j.1525-1438.2005.15353.x

  15. You have free access to this content
    Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer

    International Journal of Cancer

    Volume 127, Issue 2, 15 July 2010, Pages: 257–268, Kuzhuvelil B. Harikumar, Ajaikumar B. Kunnumakkara, Gautam Sethi, Parmeswaran Diagaradjane, Preetha Anand, Manoj K. Pandey, Juri Gelovani, Sunil Krishnan, Sushovan Guha and Bharat B. Aggarwal

    Version of Record online : 11 NOV 2009, DOI: 10.1002/ijc.25041

    Corrected by:

    Errata: Erratum

    Vol. 137, Issue 12, E21, Version of Record online: 9 OCT 2015

  16. You have full text access to this OnlineOpen article
    Overexpression of heat shock protein 27 (HSP27) increases gemcitabine sensitivity in pancreatic cancer cells through S-phase arrest and apoptosis

    Journal of Cellular and Molecular Medicine

    Volume 19, Issue 2, February 2015, Pages: 340–350, Yang Guo, Andreas Ziesch, Sandra Hocke, Eric Kampmann, Stephanie Ochs, Enrico N. De Toni, Burkhard Göke and Eike Gallmeier

    Version of Record online : 21 OCT 2014, DOI: 10.1111/jcmm.12444

  17. You have full text access to this OnlineOpen article
    An Open-label Phase 1 Dose-escalation Clinical Trial of a Single Intravenous Administration of Gemcitabine in Dogs with Advanced Solid Tumors

    Journal of Veterinary Internal Medicine

    Volume 29, Issue 2, March/April 2015, Pages: 620–625, L. Marconato, R. Finotello, U. Bonfanti, M. Dacasto, L. Beatrice, S. Pizzoni, V.F. Leone, G. Balestra, T. Furlanello, C. Rohrer Bley and L. Aresu

    Version of Record online : 27 MAR 2015, DOI: 10.1111/jvim.12557

  18. Advanced or Metastatic Pancreatic Cancer: Molecular Targeted Therapies

    Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine

    Volume 77, Issue 6, November/December 2010, Pages: 606–619, Soley Bayraktar and Caio M. Rocha-Lima

    Version of Record online : 23 NOV 2010, DOI: 10.1002/msj.20217

  19. Efficacy of a Poly-L-Glutamic Acid-Gemcitabine Conjugate in Tumor-Bearing Mice

    Drug Development Research

    Volume 73, Issue 3, May 2012, Pages: 120–129, Lik Voon Kiew, Soon Keng Cheong, Ernidila Ramli, Khalifah Sidik, Tuck Meng Lim and Lip Yong Chung

    Version of Record online : 7 MAY 2012, DOI: 10.1002/ddr.21012

  20. You have free access to this content
    Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer

    Cancer

    Volume 116, Issue 22, 15 November 2010, Pages: 5325–5335, Motofumi Tanaka, Milind Javle, Xiaoqun Dong, Cathy Eng, James L. Abbruzzese and Donghui Li

    Version of Record online : 3 NOV 2010, DOI: 10.1002/cncr.25282